Form 4: Waters Director Acquires Restricted Stock and Options

Sentiment:

Insider Transaction Report


Linda Baddour, a Director at Waters Corp, acquired 23 shares of common stock and 57 stock options as part of a compensation package.

Summary

  • Linda Baddour, a Director of Waters Corp /DE/ (WAT), acquired 23 shares of common stock.
  • These 23 shares of common stock are subject to restrictions that will lapse with respect to 100% of the shares on February 9, 2027.
  • Following this transaction, Linda Baddour beneficially owns 2,899 shares of common stock.
  • Additionally, Linda Baddour acquired 57 stock options with an exercise price of $319.44.
  • All 57 stock options will vest and become exercisable on February 9, 2027, and have an expiration date of February 25, 2036.
  • Following this transaction, Linda Baddour beneficially owns 57 stock options.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive signal, indicating a director's continued alignment with shareholder interests through equity compensation, though it is a routine event.

Positives

  • The acquisition of common stock and stock options by a director aligns their interests with long-term shareholder value.
  • The transaction represents a standard form of equity compensation for directors, indicating continued engagement with the company's performance.

Negatives

  • The acquired common stock is restricted and not immediately liquid, with restrictions lapsing on February 9, 2027.
  • The acquired stock options are unvested and not immediately exercisable, vesting on February 9, 2027.

Future Outlook

The acquired restricted common stock and stock options are scheduled to vest and become exercisable on February 9, 2027, indicating a future increase in the director's unrestricted equity holdings.

Industry Context

StockSavvy.ai notes that insider acquisitions, particularly by directors through equity compensation, are a common practice across industries. Such grants are designed to align the long-term interests of company leadership with those of shareholders, fostering a commitment to sustained company performance and value creation.

Comparison to Industry Standards

  • The grant of restricted stock and stock options to a director is a standard component of executive and director compensation packages in publicly traded companies, comparable to practices at peers in the life sciences and analytical instruments sector such as Thermo Fisher Scientific (TMO) or Agilent Technologies (A).

Stakeholder Impact

  • Shareholders: Increased alignment of director's financial interests with long-term company performance.

Next Steps

  • Vesting of 23 shares of common stock on February 9, 2027.
  • Vesting and exercisability of 57 stock options on February 9, 2027.

Key Dates

DateDescription
02/25/2026Transaction Date for acquisition of common stock and stock options.
02/27/2026Date the Form 4 was signed and filed.
02/09/2027Date when restrictions lapse on 100% of the acquired common stock and when all stock options vest and become exercisable.
02/25/2036Expiration Date for the acquired stock options.

Recommendation

hold

The acquisition of restricted stock and stock options by a director is a routine compensation event that aligns the director's interests with long-term shareholder value. While positive, it does not represent a significant change in the company's fundamental outlook to warrant a stronger recommendation.

Keywords

Waters Corp, WAT, Insider Transaction, Form 4, Stock Options, Restricted Stock, Director Compensation, Linda Baddour

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.